DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells

Molecular Therapy

Volumn 13, Issue 4, 2006, Pages 776-785

  Fredriksen, Agnete B ^a   Sandlie, Inger ^a   Bogen, Bjarne ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Antigen presenting cells; Cancer; Electroporation; Immunotherapy; Naked DNA; Targeting; Vaccine

Indexed keywords

DNA VACCINE; HOMODIMER; HYBRID PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLASMID DNA; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CONTROLLED STUDY; DIMERIZATION; DRUG MECHANISM; DRUG TARGETING; ELECTROPORATION; GENE TARGETING; IMMUNOGENICITY; LYMPHOCYTE FUNCTION; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PLASMID; PROTEIN SECRETION; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; DIMERIZATION; ELECTROPORATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULIN IDIOTYPES; INJECTIONS, INTRAMUSCULAR; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MICE, SCID; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; MULTIPLE MYELOMA; NEOPLASMS, EXPERIMENTAL; PLASMIDS; RECOMBINANT FUSION PROTEINS; TIME FACTORS; VACCINATION; VACCINES, DNA;

ANIMALIA;

EID: 33645521225     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2005.10.019     Document Type: Article

References (48)

1. J.J. Donnelly J.B. Ulmer J.W. Shiver M.A. Liu DNA vaccines Annu. Rev. Immunol. 15 1997 617-648
2. A. Henke DNA immunization - A new chance in vaccine research? Med. Microbiol. Immunol. (Berlin) 191 2002 187-190
3. S. Calarota et. al. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients Lancet 351 1998 1320-1325
4. R.R. MacGregor et. al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response J. Infect. Dis. 178 1998 92-100
5. R. Wang et. al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine Science 282 1998 476-480
6. J.M. Timmerman et. al. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma Cancer Res. 62 2002 5845-5852
7. H. Aihara J. Miyazaki Gene transfer into muscle by electroporation in vivo Nat. Biotechnol. 16 1998 867-870
8. I. Mathiesen Electropermeabilization of skeletal muscle enhances gene transfer in vivo Gene Ther. 6 1999 508-514
9. L.M. Mir et. al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses Proc. Natl. Acad. Sci. USA 96 1999 4262-4267
10. Z. Xiang H.C. Ertl Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines Immunity 2 1995 129-135
11. W.R. Weiss et. al. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine J. Immunol. 161 1998 2325-2332
12. S.M. Sumida et. al. Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines J. Clin. Invest. 114 2004 1334-1342
13. H. Kawamura J.A. Berzofsky Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin J. Immunol. 136 1986 58-65
14. G. Baier G. Baier-Bitterlich D.J. Looney A. Altman Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro J. Virol. 69 1995 2357-2365
15. D.P. Snider D.M. Segal Targeted antigen presentation using crosslinked antibody heteroaggregates J. Immunol. 139 1987 1609-1616
16. E. Lunde L.A. Munthe A. Vabo I. Sandlie B. Bogen Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells Nat. Biotechnol. 17 1999 670-675
17. R.G. Lynch R.J. Graff S. Sirisinha E.S. Simms H.N. Eisen Myeloma proteins as tumor-specific transplantation antigens Proc. Natl. Acad. Sci. USA 69 1972 1540-1544
18. M. Bendandi et. al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma Nat. Med. 5 1999 1171-1177
19. J.M. Timmerman Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: Clinical and immune responses in 35 patients Blood 99 2002 1517-1526
20. A.D. Syrengelas R. Levy DNA vaccination against the idiotype of a murine B cell lymphoma: Mechanism of tumor protection J. Immunol. 162 1999 4790-4795
21. F.K. Stevenson et. al. Idiotypic DNA vaccines against B-cell lymphoma Immunol. Rev. 145 1995 211-228
22. + T cells and immunosurveillance of B-cell tumors Proc. Natl. Acad. Sci. USA 91 1994 5700-5704
23. + T cells confer idiotype-specific tumor resistance in the absence of antibodies Eur. J. Immunol. 25 1995 3079-3086
24. A.D. Syrengelas T.T. Chen R. Levy DNA immunization induces protective immunity against B-cell lymphoma Nat. Med. 2 1996 1038-1041
25. M.H. Tao R. Levy Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma Nature 362 1993 755-758
26. A. Biragyn K. Tani M.C. Grimm S. Weeks L.W. Kwak Genetic fusion of chemokines to a self tumor antigen induces protective. T-cell dependent antitumor immunity Nat. Biotechnol. 17 1999 253-258
27. H.I. Huang et. al. Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand Int. J. Cancer 108 2004 696-703
28. C.A. King et. al. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma Nat. Med. 4 1998 1281-1286
29. I. Hakim S. Levy R. Levy A nine-amino acid peptide from IL-1beta augments antitumor immune responses induced by protein and DNA vaccines J. Immunol. 157 1996 5503-5511
30. B. Bogen R. Snodgrass J.P. Briand K. Hannestad Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region Eur. J. Immunol. 16 1986 1379-1384
31. B. Bogen J.D. Lambris Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule EMBO J. 8 1989 1947-1952
32. T.E. Tjelle et. al. Monoclonal antibodies produced by muscle after plasmid injection and electroporation Mol. Ther. 9 2004 328-336
33. D. Noel et. al. High in vivo production of a model monoclonal antibody on adenoviral gene transfer Hum. Gene Ther. 13 2002 1483-1493
34. A.D. Lewis R. Chen D.C. Montefiori P.R. Johnson K.R. Clark Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer J. Virol. 76 2002 8769-8775
35. E. Lunde K.H. Western I.B. Rasmussen I. Sandlie B. Bogen Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies J. Immunol. 168 2002 2154-2162
36. E. Gronevik et. al. DNA transfection of mononuclear cells in muscle tissue J. Gene Med. 5 2003 909-917
37. R.D. Weeratna T. Wu S.M. Efler L. Zhang H.L. Davis Designing gene therapy vectors: Avoiding immune responses by using tissue-specific promoters Gene Ther. 8 2001 1872-1878
38. T.M. Fu et. al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes Mol. Med. 3 1997 362-371
39. M.A. Chattergoon T.M. Robinson J.D. Boyer D.B. Weiner Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells J. Immunol. 160 1998 5707-5718
40. C. Condon S.C. Watkins C.M. Celluzzi K. Thompson L.D. Falo Jr. DNA-based immunization by in vivo transfection of dendritic cells Nat. Med. 2 1996 1122-1128
41. F.D. Batista D. Iber M.S. Neuberger B cells acquire antigen from target cells after synapse formation Nature 411 2001 489-494
42. + T cells Proc. Natl. Acad. Sci. USA 97 2000 2697-2702
43. K.J. Kim C. Kanellopoulos-Langevin R.M. Merwin D.H. Sachs R. Asofsky Establishment and characterization of BALB/c lymphoma lines with B cell properties J. Immunol. 122 1979 549-554
44. B. Bogen B. Malissen W. Haas Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules Eur. J. Immunol. 16 1986 1373-1378
45. T. Olafsen I.B. Rasmussen L. Norderhaug O.S. Bruland I. Sandlie IgM secretory tailpiece drives multimerisation of bivalent scFv fragments in eukaryotic cells Immunotechnology 4 1998 141-153
46. L. Norderhaug T. Olafsen T.E. Michaelsen I. Sandlie Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells J. Immunol. Methods 204 1997 77-87
47. M.S. Neuberger Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells EMBO J. 2 1983 1373-1378
48. H.N. Eisen E.S. Simms M. Potter Mouse myeloma proteins with anti-hapten antibody activity: The protein produced by plasma cell tumor MOPC-315 Biochemistry 7 1968 4126-4134